Leeds Teaching Hospitals NHS Trust is conducting a nine-month trial of artificial intelligence (AI) software developed by Densitas, a Canadian company, to assess mammogram quality and identify positioning errors. The study, funded by the Leeds Hospital Charity, aims to evaluate the health economic impacts of the technology and enhance quality assurance in radiology.
Currently, radiographers manually review mammograms for errors, which is time-consuming and subjective. In contrast, the AI software provides radiographers with data on mammogram performance, image quality, and positioning errors, allowing them to identify areas for improvement and access relevant training resources.
The goal is to enhance the quality of breast cancer care and alleviate administrative burdens on the workforce. The trial follows a previous AI study conducted by the trust, which involved using AI alongside human readers to analyze mammograms for cancer indicators.
Article written by Cora Lydon